INBX US Equity
Inhibrx Biosciences, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 2007919 · FY ends Dec 31$101.48
+6.86 (+7.25%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 3.3M |
| % of shares out | 22.7% |
| Days to cover | 15.6 |
| Δ vs 2026-07-15 | -2.7% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 3,341,210 | -2.7% | 213,594 | 15.6 |
| 2026-07-15 | 3,433,872 | -0.4% | 379,873 | 9.0 |
| 2026-06-30 | 3,447,032 | +4.5% | 347,713 | 9.9 |
| 2026-06-15 | 3,299,693 | +3.8% | 321,930 | 10.3 |
| 2026-05-29 | 3,179,335 | +8.4% | 341,252 | 9.3 |
| 2026-05-15 | 2,932,658 | +7.3% | 654,241 | 4.5 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
